ChemDiv to Participate in the EF Hutton Annual Global Conference, May 15, 2024
13 May 2024 //
PR NEWSWIRE
ChemDiv Marks a Milestone as Orionis` Novel Immunotherapy Enters Ph I Trials
03 Jan 2024 //
PR NEWSWIRE
ChemDiv Helps Advance Viriom`s Influenza Treatment
19 Dec 2023 //
PR NEWSWIRE
Veteran Pharma and Biotech Executive Bill Farley Named New CEO of ChemDiv
18 Dec 2023 //
PR NEWSWIRE
ChemDiv Presented Data for The Best-in-Class Selective FLT3 Candidate
12 Dec 2023 //
PR NEWSWIRE
ChemDiv Welcomes Peter Dmitriev and David Stark to Business Development Team
25 Oct 2023 //
PR NEWSWIRE